Publications

Sort by: Date | Author | Title

Clausen, M., Segel, E., Brandsborg, M. & D'Amore, F. A. (2011). Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune trombocytopenic purpura. European Journal of Haematology, 86 (3), 256-9.

Clausen, M. R., Segel, E. K., Brandsborg, M. & d'Amore, F. (2011). Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura. European Journal of Haematology, 86(3), 256-9. https://doi.org/10.1111/j.1600-0609.2010.01561.x

D'Amore, F. A., Madsen, J., Nielsen, R., Engebjerg, M., Sørensen, H. & Bukh, A. (2010). Use of statins and prognosis in patients with CD-20-positive "De novo" diffuse large b cell lymphoma (DLBCL) treated with rituximab containing regimens. Haematologica, 282.

Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Eriksen, P. L., Honoré, B. & Mortensen, F. V. (2019). Upregulation of ureagenesis may be pivotal for survival of post-hepatectomy liver failure in rats. Poster session presented at 13th Congress of the European – African Hepato-Pancreato-Biliary Association, Amsterdam, Netherlands.

Madsen, C., Clausen, M. R., Plesner, T. L., Pasanen, A., Kuismanen, T., Bentzen, H. H., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Rønnov-Jessen, D., Jensen, K. R., Pettinger, A. M., Ludvigsen, M., Leppä, S. & d'Amore, F. A. (2018). Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study. Blood Advances, 2(13), 1562-1571. https://doi.org/10.1182/bloodadvances.2018017673

Madsen, C., Clausen, M. R., Ludvigsen, M., Plesner, T. L. & D'Amore, F. A. (2016). Upfront Rituximab Maintenance after Induction Therapy Improves Outcome and Reduces the Risk of Histological Transformation in Patients with Follicular Lymphoma – Real World Data form a Danish Population-Based Cohort.

D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Ôsterborg, A., Merup, M., Brown, P. D. N., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Gadeberg, OV., Sundström, C., Delabie, J., Ralfkiær, E. M., Vornanen, M. & Toldbod, H. (2012). Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01). Journal of Clinical Oncology, 30(25), 3093-3099.

Madsen, C., Pedersen, M. B., Segel, E., Bendix, K., Jensen, B. A., Jensen, P., Moelller, M. B., Johansen, P., Munksgaard, L., Brown, P. & D'Amore, F. A. (2013). upfront autologous stem-cell transplantation in transformed indolent non-hodgkins lymphoma: An outcome analysis. Hematological Oncology, 31.

Simonsen, A. T., Bill, M., Rosenberg, C. A., Hansen, M. H., Møller, P. L., Kjeldsen, E., Johansen, K. D., Ommen, H. B., Nederby, L., Aggerholm, A., Hokland, P. & Ludvigsen, M. (2020). Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression. Leukemia Research, 92, Article 106350. https://doi.org/10.1016/j.leukres.2020.106350

Andersen, M. D., Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S., Clausen, M. & d'Amore, F. (2015). Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome. European Journal of Haematology, 252-259. https://doi.org/10.1111/ejh.12583

Enemark, M. B., Hybel, T. E., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L., Hamilton-Dutoit, S., D’amore, F. & Ludvigsen, M. (2022). Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. Cancers, 14(5), Article 1316. https://doi.org/10.3390/cancers14051316

Vase, M. Ø., Maksten, E. F., Bendix, K., Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S., Jespersen, B., Kampmann, J., Rabinovich, G. A., Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014). Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder. Blood, 124(21).

Vase, M. Ø., Maksten, E. F., Bendix, K., Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S., Jespersen, B., Kampmann, J., Rabinovich, G. A., Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014). Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder. Poster session presented at ASH 2014 American Society of Hematology, San Francisco, United States.

Kamper, P., Bendix, K., Hamilton-Dutoit, S., Honoré, B., Nyengaard, J. R. & d'Amore, F. (2011). Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica, 96(2), 269-76. https://doi.org/10.3324/haematol.2010.031542

Andersen, M. D., Wolter, K., Enemark, M. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M. & Kamper, P. (2025). Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma. Journal of Pathology: Clinical Research, 11(4), Article e70038. https://doi.org/10.1002/2056-4538.70038

Johnson, PWM., Federico, M., Kirkwood, AA., Fossa, A., Berkahn, L., Carella, AM., D'Amore, F. A., Enblad, G., Franceschetto, A., Fulham, M., Luminari, S., O'Doherty, M., Patrick, P., Roberts, T., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. ... Barrington, SF. (2016). Treatment adaptation guided by interim PET scan in advanced Hodgkin lymphoma. The New England Journal of Medicine, 374(25), 2419-29. https://doi.org/10.1056/NEJMoa1510093.

Ludvigsen, M., Kamper, P., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011). Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.

Ludvigsen, M. & Honoré, B. (2018). Transcriptomics and Proteomics: Integration? In Transcriptomics and proteomics: Integration? (pp. 1-9)

Snipsøyr, M. G., Wiggers, H., Ludvigsen, M., Stensballe, A., Vorum, H., Poulsen, S. H., Rasmussen, L. M., Petersen, E. & Honoré, B. (2020). Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis. International Journal of Infectious Diseases, 96, 73-81. https://doi.org/10.1016/j.ijid.2020.02.026

Vineis, P. & d'Amore, F. A. (1992). The role of occupational exposure and immunodeficiency in B-cell malignancies. Working Group on Epidemiology of Hematolymphopoietic Malignancies in Italy. Epidemiology, 3((3)), 266-70.

Coiffier, B., Federico, M., Caballero, D., Dearden, C., Morschhauser, F., Jäger, U., Trümper, L., Zucca, E., Gomes da Silva, M., Pettengell, R., Weidmann, E., d'Amore, F., Tilly, H. & Zinzani, P. L. (2014). Therapeutic options in relapsed or refractory peripheral T-cell lymphoma. Cancer Treatment Reviews, 40(9), 1080-1088. https://doi.org/10.1016/j.ctrv.2014.08.001

Agostinelli, C., Gallamini, A., Rigacci, L., Vitolo, U., Stracqualursi, L., Piccaluga, P., Stelitano, C., Patti, C., Argani, L., Broccoli, A., Levis, A., D'Amore, F. A., Zinzani, P. & Pileri, SA. (2011). The prognostic value of biologic markers in classical Hodgkin Lymphoma (CHL) patients. Annals of Oncology, 22(4), 206.

Andersen, MP., Kamper, P., Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S. J., D'Amore, F. A. & Clausen, MR. (2013). The number of tumour-infiltrating mast cells correlates with adverse prognosis in mixed cellularity, but not nodular sclerosis type, classical Hodgkin lymphoma. Haematologica.

Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A. L., Fend, F., Friedberg, J. W., Gaulard, P., Ghia, P., Horwitz, S. M., King, R. L., Salles, G. ... Zelenetz, A. D. (2022). The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood, 140(11), 1229-1253. https://doi.org/10.1182/blood.2022015851

Andersen, M. D., Kamper, P., d’Amore, A., Clausen, M., Bentzen, H. & d'Amore, F. (2019). The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor^†. Leukemia & Lymphoma, 60(4), 927-933. https://doi.org/10.1080/10428194.2018.1515939

Agostinelli, C., Gallamini, A., Stracqualursi, L., Agati, P., Tripodo, C., Fuligni, F., Sista, M. T., Fanti, S., Biggi, A., Vitolo, U., Rigacci, L., Merli, F., Patti, C., Romano, A., Levis, A., Trentin, L., Stelitano, C., Borra, A., Piccaluga, P. P. ... Pileri, S. A. (2016). The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study. The Lancet Haematology, 3(10), e467-e479. https://doi.org/10.1016/S2352-3026(16)30108-9

Clausen, M. R., Leppa, S., Brown, P. D. N., Goerloev, J. S., Panny, M., Willenbacher, W., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulczynski, E. J., Kamper, P., Gormsen, L. C., Mortensen, J., Lauritzsen, G., Relander, T. & d'Amore, F. (2016). The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial). Blood, 128(22), 1782-1782. https://doi.org/10.1182/blood-2016-07-726505

Cederleuf, H., Bjerregård Pedersen, M., Jerkeman, M., Relander, T., d'Amore, F. & Ellin, F. (2017). The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study. British Journal of Haematology, 178(5), 739-746. https://doi.org/10.1111/bjh.14740

Møller, M., d'Amore, F. A. & Christensen, BE. (1994). Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. European Journal of Cancer, 30a((12)), 1760-64.

D'Amore, F. A., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L. & Pedersen, M. B. (2014). T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up. Annals of Oncology.

Segel, E., Sørensen, B., D'Amore, F. A. & Hokland, P. (2010). Successful peripheral blood stem cell harvest in mobilization-refractory lymphoma patients. Bone Marrow Transplantation, 45(suppl. 2), 258.

Christensen, M. S., Vestergaard, J. M., d'Amore, F., Gørløv, J. S., Toft, G., Ramlau-Hansen, C. H., Stokholm, Z. A., Iversen, I. B., Nissen, M. S. & Kolstad, H. A. (2018). Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers. Epidemiology, 29(3), 342-351. https://doi.org/10.1097/EDE.0000000000000819

Ludvigsen, M., Kamper, P., Sørensen, B. S., Hamilton Dutoit, S. J., Bendix, K., Møller, M. B., Alsner, J., D'Amore, F. A. & Honoré, B. (2013). Specific degradation pattern of peroxiredoxin-1 correlates with adverse outcome in classical Hodgkin lymphoma patients..

Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021). Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies. European Journal of Haematology, Supplement, 107(1), 81-91. https://doi.org/10.1111/ejh.13621

Vajavaara, H., Mortensen, J. B., Leivonen, S.-K., Hansen, I. M., Ludvigsen, M., Holte, H., Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021). Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers, 13(3), Article 398. https://doi.org/10.3390/cancers13030398

Hershenfeld, S. A., Tobin, J. W. D., Shelton, V., Calvente, L., Lajkosz, K., Liu, T., Brodtkorb, M., d'Amore, F. A., Ludvigsen, M., Baetz, T., LeBrun, D., Johnson, N., Crump, M., Hong, M., Kuruvilla, J., Tremblay-LeMay, R., MacManus, M., Tsang, R., Hodgson, D. C. ... Kridel, R. (2024). Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. British Journal of Haematology, 205(5), 1810-1814. https://doi.org/10.1111/bjh.19698

Christensen, B., Ludvigsen, M., Nellemann, B., Kopchick, J. J., Honoré, B. & Jørgensen, J. O. L. (2015). Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers. PLoS One, 10(2), e0117119. https://doi.org/10.1371/journal.pone.0117119

Andersen, M. N., Ludvigsen, M., Abildgaard, N., Petruskevicius, I., Hjortebjerg, R., Bjerre, M., Honoré, B., Møller, H. J. & Andersen, N. F. (2017). Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation. OncoTargets and Therapy, 10, 1977-1982. https://doi.org/10.2147/OTT.S124321

Kwong, YL., Kim, SJ., Tse, E., Oh, SJ., Kwak, JY., Eom, HS., Do, YR., Mun, YC., Lee, SR., Shin, HJ., Suh, C., Chuang, SS., Tan, D., Lim, ST., Izutsu, K., Suzuki, R., Relander, T., d'Amore, F. A., Schmitz, N. ... Kim, WS. (2018). Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma. Annals of Oncology, 29(1), 256–263. https://doi.org/10.1093/annonc/mdx684

Molle, I., Petruskevicius, I., Kamper, P. & d'Amore, F. (2022). Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases. Case Reports in Hematology, 2022, Article 9722787. https://doi.org/10.1155/2022/9722787

Antiga, E., Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A., D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. ... Marzano, A. V. (2023). S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology & Venereology, 37(6), 1118-1134. https://doi.org/10.1111/jdv.18931

El-Galaly, T. C., d'Amore, F., Mylam, K. J., de Nully Brown, P., Bøgsted, M., Bukh, A., Specht, L., Loft, A., Iyer, V., Hjorthaug, K., Nielsen, A. L., Christiansen, I., Madsen, C., Johnsen, H. E. & Hutchings, M. (2012). Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography-Staged Treatment-Naive Patients With Hodgkin Lymphoma. Journal of Clinical Oncology, 30(36), 4508-4514. https://doi.org/10.1200/JCO.2012.42.4036

El-Galaly, T. C. E., D'Amore, F. A., Brown, P. D. N., Christiansen, I., Specht, L., Loft, A., Bukh, A., Johnsen, H. E., Madsen, C. & Hutchings, M. (2011). Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging. Poster session presented at ASH, San Diego, United States.

El-Galaly, T. C., D'Amore, F. A., Brown, P. D. N., Christiansen, I., Spect, L., Loft, A., Bukh, A., Johnsen, HE., Madsen, C. & Hutchings, M. (2011). Routine bone marrow biopsy adds little diagnostic information in patients with newly diagnosed Hodgkin lymphoma undergoing PET/CT staging. Blood, 118, 2627.

El-Galaly, T., Mylam, K. J., Bøgsted, M., Brown, P., Rossing, M., Gang, A. O., Haglund, A., Arboe, B., Clausen, M. R., Jensen, P., Pedersen, M., Bukh, A., Jensen, B. A., Poulsen, C. B., D'Amore, F. & Hutchings, M. (2014). Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. American Journal of Hematology, 89(6), 575-580. https://doi.org/10.1002/ajh.23688, https://doi.org/10.1002/ajh.23688

Clausen, M., Segel, E., Brandsborg, M. & D'Amore, F. A. (2011). Rituximab-induced long term remission in heavily pretreated, chronic idiopathic thrombochytopenic purpura. European Journal of Haematology, 86(3), 256-59.

Lugtenburg, P. J., De Nully Brown, P., Van der Holt, B., D'Amore, F. A., Koene, H. R., De Jongh, E., Fijnheer, R., Van Esser, J. W., Bohmer, L. H., Pruijt, J. F., Verhoef, G. E., Hoogendoorn, M., Bilgin, M. Y., Nijland, M., Van der Burg-De Graauw, N. C., Oosterveld, M., Jie, K. S. G., Larsen, T. S., Van der Poel, M. W. ... Zijlstra-Baalbergen, J. M. (2020). Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). Journal of Clinical Oncology, 38(29), 3377-3387. https://doi.org/10.1200/JCO.19.03418

Ludvigsen, L. U. P., Åsberg, A., Spetalen, S., Sørensen, M. D., Hamilton-Dutoit, S., Gramkow, A. M., Christiansen, C. F., Kro, G. B., Thomsen, M. K., Ulrichsen, S. P., Pedersen, R. M., Holte, H., Thiesson, H. C., Bjerre, A., D'Amore, F., Dahle, D. O., Jespersen, B., Jensen-Fangel, S. & Reisæter, A. V. (2025). Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients: an observational cohort study from Norway and western Denmark. American Journal of Transplantation, 25(7), 1547-1560. https://doi.org/10.1016/j.ajt.2025.01.035

Sorensen, E. F., Hybel, T. E. & Ludvigsen, M. (2025). Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'. AIDS, 39(4), 481-481. https://doi.org/10.1097/QAD.0000000000004139

Johnson, P., Federico, M., Fossa, A., O'Doherty, M., Roberts, T., Stevens, L., Smith, P., Kirkwood, A., Anghe, G., Trotman, J., Berkahn, L., D'Amore, F. A., Enblad, G., Luminari, S., Viney, Z., Radford, J. & Barrington, S. (2013). Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study. Hematological Oncology, 31, 138.

Displaying results 1 to 50 out of 284

Revised 15.03.2021

Francesco Annibale d'Amore